研究单位:[1]Green Valley (Shanghai) Pharmaceuticals Co., Ltd.[2]Beijing Anding Hospital, Capital Medical University,Beijing,Beijing,China[3]Beijing Hospital,Beijing,Beijing,China[4]Xuanwu Hospital, Capital Medical University,Beijing,Beijing,China[5]The First Affiliated Hopsital of Xiamen University,Xiamen,Fujian,China[6]The First Affiliated Hopsital of Guangzhou Medical University,Guangzhou,Guangdong,China[7]The Second Affiliated Hopsital of Guangzhou Medical University,Guangzhou,Guangdong,China[8]The First People's Hospital of Nanning,Nanning,Guangxi,China[9]Shijiazhuang People's Hospital,Shijiazhuang,Hebei,China[10]The First Hospital of Hebei Medical University,Shijiazhuang,Hebei,China[11]The Second Hopsital of Hebei Medical University,Shijiazhuang,Hebei,China[12]Tangshan Workers' Hospital,Tangshan,Hebei,China[13]The First Affiliated Hopsital of Nanyang Medical College,Nanyang,Henan,China[14]Henan Provincial People's Hospital,Zhengzhou,Henan,China[15]Chenzhou First People's Hospital,Chenzhou,Hunan,China[16]Yueyang Central Hospital,Yueyang,Hunan,China[17]Huai'an Second People's Hospital,Huai'an,Jiangsu,China[18]Nanjing Brain Hospital,Nanjing,Jiangsu,China[19]Affiliated Hospital of Nantong University,Nantong,Jiangsu,China[20]The Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,China[21]Yangzhou First People's Hospital,Yangzhou,Jiangsu,China[22]Jiujiang University Affiliated Hospital,Jiujiang,Jiangxi,China[23]The Second Affiliated Hopsital of Nanchang University,Nanchang,Jiangxi,China[24]The First Bethune Hospital of Jilin University,Changchun,Jilin,China[25]Qilu Hospital of Shandong University,Jinan,Shandong,China[26]Shandong Provincial Hospital,Jinan,Shandong,China[27]Yantai Yuhuangding Hospital,Yantai,Shandong,China[28]Tianjin People's Hospital,Tianjin,Tianjin,China[29]The Second Hospital of Jiaxing,Jiaxing,Zhejiang,China
研究目的:
The primary purpose of this study is to confirm the clinical efficacy and mechanism of action of GV-971, and identify incidence of known adverse reactions in long-term use and observe new adverse reactions, providing more guidance for clinical use.